The transcriptional repressor REV-ERB as a novel target for disease

Aug 3, 2020Bioorganic & medicinal chemistry letters

REV-ERB protein as a new target for treating disease

AI simplified

Abstract

REV-ERB is a transcription factor linked to various physiological processes including circadian rhythm and metabolism.

  • REV-ERB is implicated in the regulation of immune function and metabolism.
  • Current understanding highlights the potential of REV-ERB as a drug target for treating several diseases.
  • The modulation of REV-ERB can occur through both endogenous factors and synthetic ligands.
  • There is a recognized need for higher quality synthetic ligands to enhance the validation of REV-ERB as a therapeutic target.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free